Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
The historical rank and industry rank for Zhongzhu Healthcare Holding Co's EV-to-FCF or its related term are showing as below:
SHSE:600568'
s EV-to-FCF Range Over the Past 10 Years
Min: -8459.14 Med: -7.9 Max: 258.83
Current: -355.35
During the past 13 years, the highest EV-to-FCF of Zhongzhu Healthcare Holding Co was 258.83. The lowest was -8459.14. And the median was -7.90.
SHSE:600568's EV-to-FCF is ranked worse than 100% of 565
companies
in the Drug Manufacturers industry
Industry Median: 20.96
vs SHSE:600568: -355.35
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zhongzhu Healthcare Holding Co (SHSE:600568) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Zhongzhu Healthcare Holding Co's PE Ratio (TTM) for today is calculated as:
Zhongzhu Healthcare Holding Co's share price for today is ¥2.31.
Zhongzhu Healthcare Holding Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-0.062.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Zhongzhu Healthcare Holding Co EV-to-FCF Related Terms
Zhongzhu Healthcare Holding Co EV-to-FCF Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Zhongzhu Healthcare Holding Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zhongzhu Healthcare Holding Co EV-to-FCF vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zhongzhu Healthcare Holding Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Zhongzhu Healthcare Holding Co's EV-to-FCF falls into.
Zhongzhu Healthcare Holding Co's current Enterprise Value is ¥4,240.8 Mil.
Zhongzhu Healthcare Holding Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-11.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zhongzhu Healthcare Holding Co (SHSE:600568) has a EV-to-FCF of -355.35 as of Jul. 19, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zhongzhu Healthcare Holding Co and its competitors. According to the industry distribution chart, Zhongzhu Healthcare Holding Co ranks #999999 out of 565 companies in the Drug Manufacturers industry.
Is Zhongzhu Healthcare Holding Co's EV-to-FCF too high?
Zhongzhu Healthcare Holding Co's current EV-to-FCF is -355.35. Based on the distribution chart, Zhongzhu Healthcare Holding Co ranks #999999 out of 565 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Zhongzhu Healthcare Holding Co has a GF Score™ of 54/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Zhongzhu Healthcare Holding Co's EV-to-FCF compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zhongzhu Healthcare Holding Co ranks #999999 out of 565 companies for EV-to-FCF. This places Zhongzhu Healthcare Holding Co in the lower half of its industry. The industry median EV-to-FCF is 20.96. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Drug Manufacturers company?
The median EV-to-FCF among Drug Manufacturers companies is 20.96, based on 565 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Zhongzhu Healthcare Holding Co and its competitors. For the Drug Manufacturers industry, the median EV-to-FCF is 20.96 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zhongzhu Healthcare Holding Co's current EV-to-FCF is -355.35. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zhongzhu Healthcare Holding Co stock overvalued right now?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co (SHSE:600568) is currently considered Modestly Overvalued. The stock's GF Value™ is ¥1.88, compared to a current price of ¥2.31 — trading 22.9% above its estimated fair value. The current EV-to-FCF is -355.35. Zhongzhu Healthcare Holding Co's overall GF Score™ is 54/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Zhongzhu Healthcare Holding Co (SHSE:600568), the current EV-to-FCF is -355.35 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Zhongzhu Healthcare Holding Co (SHSE:600568) Overvalued in 2026?
Based on GuruFocus' analysis, Zhongzhu Healthcare Holding Co stock appears to be overvalued.
The current stock price of ¥2.31 is trading 22.9% above its estimated GF Value™ of ¥1.88.
GuruFocus considers Zhongzhu Healthcare Holding Co to be Modestly Overvalued.
Key valuation signals for SHSE:600568:
EV-to-FCF: -355.35
GF Value™: ¥1.88 vs. price of ¥2.31 (22.9% above fair value)
No single metric tells the full story. See the SHSE:600568 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Zhongzhu Healthcare Holding Co Business Description
Zhongzhu Healthcare Holding Co Ltd produces and sells ophthalmic, antiviral, and anti-infective drugs in China. Its products include eye and nasal drops, injections, solid preparations, and other products. The product consists of Pearl Eye Drops, Sodium Cromolyn Eye Drops, Acyclovir Eye Drops, Hydroxybenzazole Hydrochloride Eye Drops, Acyclovir Dispersible Tablets, Gatifloxacin Tablets.
54GF Score
Get the complete analysis for SHSE:600568
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:600568 has been successfully added to your 
